Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis
- PMID: 8586522
- DOI: 10.1007/BF02550085
Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis
Abstract
The aim of this study was to examine serum angiotensin converting enzyme (SACE) activity and the renin-angiotensin-aldosterone system in patients on chronic haemodialysis during one routine dialysis session. Fourteen patients (8 men and 6 women; mean age 51.9 +/- 17 years) with end stage renal disease, receiving regular haemodialysis treatment for an average of 6 months, were studied. The patients were dialysed for 4 hours three times a week using cellulose membranes (cuprophan). After an overnight fast blood samples were taken from the patients before and after the haemodialysis session. Serum and plasma were separated and stored at -20 degrees C until assayed for SACE, plasma renin activity (PRA) and plasma aldosterone (PA). For comparison, SACE, PRA and PA were also measured in 8 patients after renal allotransplantation and on treatment with cyclosporin A (5 men, 3 women; mean age 38.9 +/- 12.3 years) and in 19 healthy subjects (13 men, 6 women; mean age 38.9 +/- 12.3 years). SACE levels in patients with chronic renal failure and on haemodialysis (17.55 +/- 9.03 nmol/ml/min) and in patients with renal transplantation (18.12 +/- 3.92) were significantly higher than those of the healthy subjects (9.27 +/- 1.67) (p < 0.0001, respectively). At the end of the dialysis session SACE levels in patients with chronic renal failure (14.9 +/- 7.19) did not increase in respect to pre-dialysis levels (17.55 +/- 9.03; p = 0.132). PRA and PA values increased after the dialysis session (p < 0.026 and p < 0.044, respectively). Correlation of SACE with PRA and PA was not demonstrated before or after the dialysis session. In patients with chronic renal failure and on haemodialysis our findings suggest that a disarrangement exists between the circulatory components of the reninangiotensin-aldosterone system before and after the dialysis session.
Similar articles
-
[Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure].Nephrologie. 1983;4(4-5):229-30. Nephrologie. 1983. PMID: 6320023 French.
-
Effect of haemodialysis on plasma ADH levels, plasma renin activity and plasma aldosterone levels in patients with end-stage renal disease.Acta Endocrinol (Copenh). 1985 Oct;110(2):207-13. doi: 10.1530/acta.0.1100207. Acta Endocrinol (Copenh). 1985. PMID: 3904290
-
Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs).Agents Actions Suppl. 1987;22:339-47. doi: 10.1007/978-3-0348-9299-5_35. Agents Actions Suppl. 1987. PMID: 2829597
-
[Renal insufficiency and renin-angiotensin-aldosterone].Nihon Rinsho. 1974 Mar;32(3):518-27. Nihon Rinsho. 1974. PMID: 4368245 Review. Japanese. No abstract available.
-
What to do with foundation therapies for heart failure for patients with end-stage kidney disease on haemodialysis.Br J Hosp Med (Lond). 2024 Apr 30;85(4):1-10. doi: 10.12968/hmed.2023.0452. Br J Hosp Med (Lond). 2024. PMID: 38708982 Review.
Cited by
-
A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.Endocrine. 2003 Aug;21(3):221-6. doi: 10.1385/ENDO:21:3:221. Endocrine. 2003. PMID: 14515005 Review.
-
Some Aspects of the Renin-Angiotensin-System in Hemodialysis Patients.Kidney Blood Press Res. 2015;40(6):614-22. doi: 10.1159/000368537. Epub 2015 Nov 29. Kidney Blood Press Res. 2015. PMID: 26618349 Free PMC article. Review.
-
Imbalanced plasma ACE and ACE2 level in the uremic patients with cardiovascular diseases and its change during a single hemodialysis session.Ren Fail. 2017 Nov;39(1):719-728. doi: 10.1080/0886022X.2017.1398665. Ren Fail. 2017. PMID: 29157100 Free PMC article.
-
Possible benefits of exogenous melatonin for individuals on dialysis: a narrative review on potential mechanisms and clinical implications.Naunyn Schmiedebergs Arch Pharmacol. 2021 Aug;394(8):1599-1611. doi: 10.1007/s00210-021-02099-x. Epub 2021 Jun 7. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 34097094 Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials